Loading
Cardio Diagnostics Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Philibert Robert, was filed 10 Sept 2024.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€54,841
8 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -56.2%Entry US$8.73 · Close at T+365 US$3.82
- -58.0%Entry US$8.94 · Close at T+365 US$3.76
- -26.2%Entry US$12.60 · Close at T+365 US$9.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.64
Analyst consensus
Income statement
RevenueUS$14.8k
EBITDA-US$6.1M-41047% margin
Net income-US$6.5M-43832.5% margin
Valuation
P/Book0.7x
Beta2.24
Balance sheet & cash
Market capUS$4.9M
Total debtUS$695.6k
Free Cash Flow-US$6.1M
Debt / Equity5%
Profitability & ownership
ROE-75.4%
ROA-44.1%
% insiders8.3%
% institutions6.5%
Last declaration on 23 September 2024
Declarations36 total
68,965 shares@ US$0.2995.2% of flowCommon StockSEC:0001486189-24-000047:0
Canonical exit: 5 Dec 2024 (T+90)
7,460 shares@ US$0.28486.9% of flowCommon StockSEC:0001486189-24-000046:1
Canonical exit: 5 Dec 2024 (T+90)
26,615 shares@ US$0.28743.6% of flowCommon StockSEC:0001486189-24-000046:0
Canonical exit: 5 Dec 2024 (T+90)
68,965 shares@ US$0.2995.2% of flowCommon StockSEC:0001486189-24-000045:0
Canonical exit: 5 Dec 2024 (T+90)
8,803 shares@ US$1.4220.1% of flowCommon StockSEC:0001486189-24-000022:0
8,803 shares@ US$1.4220.1% of flowCommon StockSEC:0001486189-24-000021:0
8,803 shares@ US$1.42100.0% of flowCommon StockSEC:0001486189-24-000024:0
8,803 shares@ US$1.4226.5% of flowCommon StockSEC:0001486189-24-000023:0
917 shares@ US$2.184.2% of flowCommon StockSEC:0001486189-24-000007:0
5,020 shares@ US$2.4914.2% of flowCommon StockSEC:0001486189-24-000001:1
5,020 shares@ US$2.4924.5% of flowCommon StockSEC:0001486189-24-000004:0
5,020 shares@ US$2.4919.6% of flowCommon StockSEC:0001486189-24-000005:0
5,020 shares@ US$2.4919.6% of flowCommon StockSEC:0001486189-24-000003:0
1,606 shares@ US$2.498.3% of flowCommon StockSEC:0001486189-24-000001:0
6,631 shares@ US$0.30164.3% of flowCommon StockSEC:0001486189-23-000040:0
3,637 shares@ US$0.54992.3% of flowCommon StockSEC:0001486189-23-000035:1
5,882 shares@ US$0.342.4% of flowCommon StockSEC:0001486189-23-000035:2
36,765 shares@ US$0.3414.8% of flowCommon StockSEC:0001486189-23-000035:3
1,653 shares@ US$1.214.2% of flowCommon StockSEC:0001486189-23-000035:0
36,765 shares@ US$0.3420.5% of flowCommon StockSEC:0001486189-23-000031:0
36,765 shares@ US$0.3420.5% of flowCommon StockSEC:0001486189-23-000030:0
36,765 shares@ US$0.3425.7% of flowCommon StockSEC:0001486189-23-000029:0
16,481 shares@ US$0.54530.5% of flowCommon StockSEC:0001486189-23-000026:1
Canonical exit: 29 Nov 2023 (T+90)
16,481 shares@ US$0.54531.5% of flowCommon StockSEC:0001486189-23-000027:1
Canonical exit: 29 Nov 2023 (T+90)
1,770 shares@ US$0.5554.8% of flowCommon StockSEC:0001486189-23-000026:0
Canonical exit: 23 Nov 2023 (T+90)
25 of 36 declarations
About Cardio Diagnostics Holdings, Inc.
On September 6, 2024, three Cardio Diagnostics Holdings, Inc. insiders bought together for EUR 44,787. Timur Dogan and Meeshanthini Dogan, both filed with the title of chief technology officer, bought EUR 18,000 each. In all, the record holds 10 purchases for EUR 81,124, with a median of EUR 8,283, and no sale.
Robert Philibert, the chief medical officer, signs 5 of these purchases, including EUR 9,919 on August 28, 2023. Stanley K. Lau, a director, has the most filings (11), with no purchase or sale; James Intrater and Oded Levy, both directors, have 4 each. The record is mostly option exercises: 23 of them, counted apart from purchases.
Read moreShow less
Nine insiders filed 35 times between December 2, 2021 and September 23, 2024, 19 of them in 2023 and 14 in 2024. Filings are published a median of 5 days after the trade. The Nasdaq-listed Health Care company has a market capitalisation of USD 4,853,529, and insiders hold 8.3%. There is no filing over the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
